This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
COPD exacerbations are associated with significant morbidity, mortality, and increased health care expenditures. The recently published Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendations have further refined the definition of an exacerbation. A better understanding of the risk factors associated with the development of an exacerbation exists, and improvements are being made in earlier detection approaches. Pharmacologic treatment strategies have been the cornerstone of effective therapy. In addition, both pharmacologic and non-pharmacologic strategies have been proven successful in the prevention of future exacerbations. Newer technologies, including the use of artificial intelligence and wearable monitoring devices, are now being used to help in the earlier detection of exacerbations. Such preventive and earlier detection strategies can help to develop a more personalized care model and improve outcomes for patients with COPD.
Footnotes
- Correspondence: Brian W Carlin MD, Sleep Medicine and Lung Health Consultants, PO Box 174, Ingomar, PA 15127. E-mail: bwcmd{at}yahoo.com
Dr Carlin has disclosed relationships with Aerogen, Monaghan Medical, and National Board for Respiratory Care.
Dr Carlin presented a version of this paper at the 59th Respiratory Care Journal Conference, COPD: Current Evidence and Implications for Practice, held June 21–22, 2022, in St Petersburg, Florida.
- Copyright © 2023 by Daedalus Enterprises
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$30.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.